期刊文献+

阿霉素冲击诱导人骨肉瘤多药耐药细胞模型 被引量:9

Experiment Models for the Study of MDR:Human Osteosarcoma Cell Sublines
下载PDF
导出
摘要 目的 :建立人骨肉瘤细胞多药耐药亚系。方法 :采用ADM间断冲击法诱导骨肉瘤细胞 ,并用免疫荧光、MTT及ABA法检测肿瘤细胞的耐药特征。结果 :本实验建立了 6株多药耐药细胞亚系MG 6 3/R1~ 6。用免疫荧光术可以检测到P gp的表达 ,MTT、ABA法显示各亚系细胞的多药耐药性明显增加 ,并且维拉帕米可以拮抗P gp的作用。结论 :MDR1/P170 在多药耐药的特性上起着至关重要的作用 ,而且这些骨肉瘤多药耐药细胞亚系为进一步研究骨肉瘤耐药特征及逆转方法打下基础。 Objective:To establish a multidrug-resistene(MDR) subline of human osteosarcoma.Methods:The authors created cell lines by short-time pulse exposure of the parent cell line to adriamycin followed by single-cell clone.MDR character was detected with immunoflorescence method and MTT,ABA Results:The authors developed six P-gp-positive,human osteosarcoma cell lines that were resistant to adriamycin MG-63/R 1~6which were higher than the cells from parent line respectively and also cross-resistant to other drugs at different degrees.There was less accumulation of the drug in resistent cell lines,AB% of MG-63/R 6 is only 9.8%.but when verapamil is used,AB% could risen to 52%.Immunoflorescence can detect significant high expression of P-gp in MDR cell lines.Conclusion:Expression of MDR1/P 170is key factor to regulate MDR phenotype of osteosarcoma.These newly described multidrug-resistent osteosarcoma cell sublines are useful models for further characterization of drug resistence in osteosarcoma and for the development of treatment protocols.
出处 《中国矫形外科杂志》 CAS CSCD 2003年第5期318-320,共3页 Orthopedic Journal of China
关键词 阿霉素 骨肉瘤 多药耐药 细胞模型 冲击治疗 Osteosarcoma Multidrug-resistance Cell-model Adriamycin(ADM)
  • 相关文献

参考文献1

  • 1曾恒 杨彩虹 陈安民.骨肉瘤预后与mdr1/P170的临床意义[J].国外医学:肿瘤学分册,2000,8:290-293.

共引文献1

同被引文献87

  • 1Xiao-qing TANG,Hu BI,Jian-qiang FENG,Jian-guo CAO.Effect of curcumin on multidrug resistance in resistant human gastric carcinoma cell line SGC7901/VCR[J].Acta Pharmacologica Sinica,2005,26(8):1009-1016. 被引量:49
  • 2徐建业,周琦,汤伟.汉防已甲素、罗通定及川芎嗪对肿瘤细胞株KBV200多药耐药性逆转作用的研究[J].重庆医学,2005,34(9):1383-1384. 被引量:9
  • 3张仲宁,喻爱喜,侯炜,祝少博,程丽,毛琳.肿瘤坏死因子相关凋亡诱导配体联合阿霉素治疗骨肉瘤[J].中华实验外科杂志,2006,23(2):141-143. 被引量:6
  • 4张晓丽,曹国宪,俞惠新,金坚.延胡索乙素逆转多药耐药性人乳腺癌细胞MCF-7[J].中药药理与临床,2005,21(6):19-21. 被引量:14
  • 5Xiang Chen,Tong-Tao Yang,Wei Wang,et al.Establishment and characterization of human osteosarcoma cell lines with different pulmonary metastatic potentials[J].Cytotechnology,2009,61(1):37-44.
  • 6Bacci G,Ferrari S,Mercuri M,et al.Neoadjuvant chemotherapy for osteosarcoma of the extremities in patients aged 41-60 years:outcome in 34 cases treated with adriamycin,cisplatinum and ifosfamide between 1984 and 1999[J].Acta Orthop,2007,78(3):377-384.
  • 7Ferrari S,Smeland S,Mercuri M,et al.Neoadjuvant chemotherapy with hith-doseIfosfamide,high-dose methotrexate,cisplatin,and doxorubicin for patients with localized osteosarcoma of the extremity:a joint study by the Italian and Scandinavian Sarcoma Groups[J].J Clin Oncol,2005,23(34):8845-8852.
  • 8Chi SN,Conkin LS,Qin J,et al.The patterns of relapse in osteosarcoma:the Memorial Sloan-Kettering experience[J].Pediatr Blood Cancer,2004,42(1):46-51.
  • 9Bielack SS,Kempf-Bielack B,Dellng G,et al.Prognostic factors in high-grade osteosarcoma of the extremities or trunk:an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols[J].J Clin Oncol,2002,20(3):776-790.
  • 10Beauvillain C,Mahe M,Bourdin S,et al.Final results of a randomized trial comparing chemotherapy plus radiotherapy with chemotherapy plus surgery plus radiotherapy in locally advanced resectable by popharyngeal carcinomas[J].Laryngoscope,1997,107:648.

引证文献9

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部